Ryan Deschner
Stock Analyst at Raymond James
(1.27)
# 1552
Out of 5,270 analysts
8
Total ratings
66.67%
Success rate
10.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ardelyx | Reiterates: Strong Buy | 15 13 | 5.07 | 156.41% | 1 | Feb 21, 2025 | |
ARS Pharmaceuticals | Maintains: Strong Buy | 26 28 | 10.16 | 175.59% | 3 | Jan 14, 2025 | |
Trevi Therapeutics | Initiates Coverage On: Outperform | 9 | 4.26 | 111.27% | 1 | Aug 30, 2024 | |
Liquidia | Upgrades: Strong Buy | 27 27 | 14.85 | 81.82% | 2 | Aug 19, 2024 | |
Omega Therapeutics | Initiates Coverage On: Outperform | 12 | n/a | n/a | 1 | Jun 18, 2024 |